Literature DB >> 29045988

Postgraduate Experiences With an Advanced Reproductive Health and Abortion Training and Leadership Program.

Alison Block1, Christine Dehlendorf, M Antonia Biggs, Sarah McNeil, Suzan Goodman.   

Abstract

BACKGROUND AND OBJECTIVES: Family physicians are critical to reproductive health service provision including miscarriage management and abortion care, but many graduates report barriers in integrating these services into practice. We designed and implemented CREATE (Continuing Reproductive Education for Advanced Training Efficacy), an elective advanced training and leadership program for senior residents aimed to help new graduates integrate miscarriage and abortion care into practice.
METHODS: We surveyed all 53 program graduates at graduation, and 47 completed a follow-up survey in March 2016. We describe program graduates' current reproductive health practices and differences by respondent characteristics. We report facilitators (or enabling factors) and barriers that graduates encountered in attempting to integrate reproductive health care into practice, as well as the perceived impact of the CREATE program.
RESULTS: Forty-two percent of CREATE graduates were providing miscarriage management and 35% were providing abortion care at the time of the follow-up survey. Factors associated with abortion provision at follow-up include strength of intention to provide at graduation and higher volume of uterine aspirations performed during residency. Graduates reported a range of barriers, including internal factors such as strength of competing interests, and external barriers such as administrative and staff resistance. Graduates found the additional procedural training, networking opportunities, and the complication simulation to be the most helpful aspects of the CREATE program.
CONCLUSIONS: The CREATE program model may provide a useful template for family medicine residencies working to incorporate advanced abortion training or other advanced procedural skills into their curricula. Future curricular interventions should consider providing additional postgraduate support, particularly in provider shortage areas.

Mesh:

Year:  2017        PMID: 29045988

Source DB:  PubMed          Journal:  Fam Med        ISSN: 0742-3225            Impact factor:   1.756


  5 in total

1.  The impact of training on self-reported performance in reproductive, maternal, and newborn health service delivery among healthcare workers in Tanzania: a baseline- and endline-survey.

Authors:  Tumbwene Mwansisya; Columba Mbekenga; Kahabi Isangula; Loveluck Mwasha; Stewart Mbelwa; Mary Lyimo; Lucy Kisaka; Victor Mathias; Eunice Pallangyo; Grace Edwards; Michaela Mantel; Sisawo Konteh; Thomas Rutachunzibwa; Secilia Mrema; Hussein Kidanto; Marleen Temmerman
Journal:  Reprod Health       Date:  2022-06-20       Impact factor: 3.355

2.  Medication for Abortion and Miscarriage in Primary Care: Important and Possible for General Internists.

Authors:  Rachel S Casas; Cynthia H Chuang
Journal:  J Gen Intern Med       Date:  2020-08       Impact factor: 5.128

3.  Exploring the impact of mifepristone's risk evaluation and mitigation strategy (REMS) on the integration of medication abortion into US family medicine primary care clinics✰,✰✰.

Authors:  Na'amah Razon; Sarah Wulf; Citlali Perez; Sarah McNeil; Lisa Maldonado; Alison Byrne Fields; Diana Carvajal; Rachel Logan; Christine Dehlendorf
Journal:  Contraception       Date:  2022-02-04       Impact factor: 3.051

4.  Future health providers' willingness to provide abortion services following decriminalisation of abortion in Chile: a cross-sectional survey.

Authors:  M Antonia Biggs; Lidia Casas; Alejandra Ramm; C Finley Baba; Sara Victoria Correa; Daniel Grossman
Journal:  BMJ Open       Date:  2019-10-30       Impact factor: 2.692

5.  Knowledge and attitudes of Irish GPs towards abortion following its legalisation: a cross-sectional study.

Authors:  Raymond O'Connor; Jane O'Doherty; Michael O'Mahony; Eimear Spain
Journal:  BJGP Open       Date:  2019-12-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.